Rhythm Pharmaceuticals, Inc. RYTM
NASDAQ · United States · Health Technology
$93.41-1.81 (-1.90%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -0.73 | -0.81 | +9.6% | $71.26M | +5.3% | +7.7%$102.78→$110.71 |
| Q1 2026 | 2026-05-05 | -0.83 | -0.86 | +3.5% | — | — | +12.9%$85.58→$96.61 |
| Q4 2025 | 2026-02-26 | -0.73 | -0.79 | +7.6% | — | — | -6.5%$99.15→$92.73 |
| Q3 2025 | 2025-11-04 | -0.82 | -0.72 | -13.9% | — | — | -12.5%$113.74→$99.47 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.